{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:37:29Z","timestamp":1792816649192,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T00:00:00Z","timestamp":1614384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T00:00:00Z","timestamp":1614384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Betty J. Foust, M.D. and Parents' Professor of Oncology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s11864-021-00829-0","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T18:21:41Z","timestamp":1614450101000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Should Loss of Appetite Be Palliated in Patients with Advanced Cancer?"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5077-4563","authenticated-orcid":false,"given":"Christopher","family":"Ehret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1081-189X","authenticated-orcid":false,"given":"Aminah","family":"Jatoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,27]]},"reference":[{"key":"829_CR1","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1200\/JCO.20.00611","volume":"38","author":"EJ Roeland","year":"2020","unstructured":"\u2022\u2022 Roeland EJ, Bohlke K, Baracos VE, et al. Management of cancer cachexia: ASCO guideline. J Clin Oncol. 2020;38:2438\u201353 These guidelines might be of value to practicing clinicians.","journal-title":"J Clin Oncol"},{"key":"829_CR2","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1089\/jpm.2019.0377","volume":"23","author":"JS Temel","year":"2020","unstructured":"\u2022\u2022 Temel JS, Sloan J, Zemla T, et al. Multi-site randomized trial of early integrated palliative and oncology care in patients with advanced lung and gastrointestinal cancer: alliance A221303. J Palliat Med. 2020;23:922\u20139 This multi-site randomized controlled trial provides balance to previous studies with respect to the role of palliative care in cancer patients.","journal-title":"J Palliat Med"},{"key":"829_CR3","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJMoa1000678","volume":"363","author":"JS Temel","year":"2010","unstructured":"Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small cell lung cancer. N Engl J Med. 2010;363:733\u201342.","journal-title":"N Engl J Med"},{"key":"829_CR4","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1097\/MPA.0000000000001629","volume":"49","author":"MN Mavros","year":"2020","unstructured":"Mavros MN, Davis LE, Hallet J, et al. Adenocarcinoma: an analysis of 10, 753 patient-reported outcome assessments. Pancreas. 2020;49:1083\u20139.","journal-title":"Pancreas"},{"key":"829_CR5","unstructured":"Rha SY, Lee Y. Stable symptom clusters and evolving symptom networks in relation to chemotherapy cycles. J Pain Sympt Manag. 2020; available on line August 2020."},{"key":"829_CR6","doi-asserted-by":"crossref","unstructured":"Grover S, Redd WD, Zhou JC, et al. High prevalence of gastrointestinal manifestations of COVID-19 infection in hospitalized patients with cancer. J Clin Gastroenterol 2020; October 27.","DOI":"10.14309\/01.ajg.0000703068.23203.58"},{"key":"829_CR7","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1007\/s00520-009-0623-5","volume":"17","author":"T Yavuzsen","year":"2009","unstructured":"Yavuzsen T, Walsh D, Davis MP, et al. Components of the anorexia-cachexia syndrome: gastrointestinal symptom correlates of cancer anorexia. Support Care Cancer. 2009;17:1531\u201341.","journal-title":"Support Care Cancer"},{"key":"829_CR8","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.3390\/cancers12071867","volume":"12","author":"S Shimose","year":"2020","unstructured":"Shimose S, Iwamoto H, Niizeki T, et al. Clinical significance of adverse events for patients with unresectable hepatocellular carcinoma treated with lenvatinib: a multicenter retrospective study. Cancers. 2020;12:1867.","journal-title":"Cancers"},{"key":"829_CR9","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/S1470-2045(09)70200-1","volume":"10","author":"C Quinten","year":"2009","unstructured":"Quinten C, Coens C, Mauer M, et al. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from the EORTC clinical trials. Lancet Oncol. 2009;10:865\u201371.","journal-title":"Lancet Oncol"},{"key":"829_CR10","doi-asserted-by":"publisher","first-page":"E31","DOI":"10.1097\/NCC.0b013e31823d52b7","volume":"35","author":"S Porter","year":"2012","unstructured":"Porter S, Millar C, Reid J. Cancer cachexia care. The contribution of qualitative research to evidence-based practice. Cancer Nursing. 2012;35:E31\u20138.","journal-title":"Cancer Nursing"},{"key":"829_CR11","doi-asserted-by":"crossref","unstructured":"Hopkinson JB. Psychosocial impact of cancer cachexia. J Cachex Sarcopenia Muscle. 2014:89\u201394.","DOI":"10.1007\/s13539-014-0142-1"},{"key":"829_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/NCC.0000000000000474","volume":"41","author":"JB Hopkinson","year":"2018","unstructured":"Hopkinson JB. The nourishing role. Exploratory qualitative research revealing unmet support needs in family carers of patients with advanced cancer and eating problems. Cancer Nursing. 2018;41:131\u20138.","journal-title":"Cancer Nursing"},{"key":"829_CR13","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/jnci\/82.13.1127","volume":"82","author":"CL Loprinzi","year":"1990","unstructured":"Loprinzi CL, Ellison NM, Schaid DJ, et al. Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. J Natl Cancer Inst. 1990;82:1127\u201332.","journal-title":"J Natl Cancer Inst"},{"key":"829_CR14","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1002\/1097-0142(197406)33:6<1607::AID-CNCR2820330620>3.0.CO;2-V","volume":"33","author":"CG Moertel","year":"1974","unstructured":"Moertel CG, Schutt AJ, Reitemeier RJ, Hahn RG. Corticosteroid therapy in preterminal gastrointestinal cancer. Cancer. 1974;33:1607\u20139.","journal-title":"Cancer"},{"key":"829_CR15","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1200\/JCO.2004.06.024","volume":"22","author":"A Jatoi","year":"2004","unstructured":"Jatoi A, Rowland K, Loprinzi CL, et al. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting. J Clin Oncol. 2004;22:2469\u201376.","journal-title":"J Clin Oncol"},{"key":"829_CR16","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1200\/JCO.2002.20.2.567","volume":"20","author":"A Jatoi","year":"2002","unstructured":"Jatoi A, Windshitl HE, Loprinzi CL, et al. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia. J Clin Oncol. 2002;20:567\u201373.","journal-title":"J Clin Oncol"},{"key":"829_CR17","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1200\/JCO.1999.17.10.3299","volume":"17","author":"CL Loprinzi","year":"1999","unstructured":"Loprinzi CL, Kugler JW, Sloan JA, et al. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia\/cachexia. J Clin Oncol. 1999;17:3299\u2013306.","journal-title":"J Clin Oncol"},{"key":"829_CR18","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","volume":"17","author":"JS Temel","year":"2016","unstructured":"Temel JS, Abernethy A, Currow DC, et al. Anamorelin in patients with non-small cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomized, double-blind phase 3 trials. Lancet Oncool. 2016;17:519\u201331.","journal-title":"Lancet Oncool"},{"key":"829_CR19","doi-asserted-by":"crossref","unstructured":"Navari RM, Pywell CM, Le-Rademacher JG, et al. Olanzapine for the treatment of advanced cancer-related chronic nausea and\/or vomiting: a randomized pilot trial. JAMA Oncol. 2020;6:895-899. This pilot study raises awareness that olanzapine might be of value for the palliation of cancer-associated loss of appetite.","DOI":"10.1001\/jamaoncol.2020.1052"},{"key":"829_CR20","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00520-009-0739-7","volume":"18","author":"RM Navari","year":"2010","unstructured":"Navari RM, Brenner MC. Treatment of cancer-related anorexia with olanzapine and megestrol acetate: a randomized trial. Support Care Cancer. 2010;18:951\u20136.","journal-title":"Support Care Cancer"},{"key":"829_CR21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.21037\/apm.2018.08.02","volume":"8","author":"MP Davis","year":"2019","unstructured":"Davis MP, Panikkar R. Sarcopenia associated with chemotherapy and targeted agents for cancer therapy. Ann Palliat Med. 2019;8:86\u2013101.","journal-title":"Ann Palliat Med"},{"key":"829_CR22","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.appet.2018.12.008","volume":"134","author":"KR Polley","year":"2019","unstructured":"Polley KR, Kamal F, Paton CM, Cooper JA. Appetite responses to high-fat diets rich in mono-unsaturated versus poly-unsaturated fats. Appetite. 2019;134:172\u201381.","journal-title":"Appetite"},{"key":"829_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.clnesp.2019.12.004","volume":"35","author":"N Schmidt","year":"2020","unstructured":"Schmidt N, Moller G, Baeksgaard L, et al. Fish oil supplementation in cancer patients. Capsules or nutritional drink supplements? A controlled study of compliance. Clin Nutr ESPEN. 2020;35:63\u20138.","journal-title":"Clin Nutr ESPEN"},{"key":"829_CR24","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3920\/BM2019.0197","volume":"11","author":"D Valent","year":"2020","unstructured":"Valent D, Arroyo L, Fabrega E, et al. Effects of a high-fat-diet supplemented with probiotics and omega3-fatty acids on appetite regulatory neuropeptides and neurotransmitters in a pig model. Benef Microbes. 2020;11:347\u201359.","journal-title":"Benef Microbes"},{"key":"829_CR25","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12944-017-0495-5","volume":"16","author":"K Werner","year":"2017","unstructured":"Werner K, Kullenberg de Gaudry D, Taylor LA, et al. Dietary supplementation with n-3-fatty acids in patients with pancreatic cancer and cachexia: marine phospholipids versus fish oil - a randomized controlled double-blind trial. Lipids Health Dis. 2017;16:104.","journal-title":"Lipids Health Dis"},{"key":"829_CR26","doi-asserted-by":"crossref","unstructured":"Ruiz Garcia V, Lopez-Briz E, Carbonell Sanchis R, et al. Megestrol acetate for treatment of anorexia-cachexia syndrome. Cochrane Database Syst Review 2013. March 28.","DOI":"10.1002\/14651858.CD004310.pub3"},{"key":"829_CR27","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1200\/JCO.1990.8.11.1797","volume":"8","author":"HB Muss","year":"1990","unstructured":"Muss HB, Case LD, Capizzi RL, et al. High- versus standard-dose megestrol acetate in women with advanced breast cancer: a phase III trial of the Piedmont Oncology Association. J Clin Oncol. 1990;8:1797\u2013805.","journal-title":"J Clin Oncol"},{"key":"829_CR28","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1007\/s00520-020-05475-0","volume":"28","author":"B Ukovic","year":"2020","unstructured":"Ukovic B, Porter J. Nutrition interventions to improve the appetite of adults undergoing cancer treatment: a systematic review. Support Care Cancer. 2020;28:4575\u201383.","journal-title":"Support Care Cancer"},{"key":"829_CR29","first-page":"234","volume":"6","author":"TR Halfdanarson","year":"2008","unstructured":"Halfdanarson TR, Thordardottir E, West CP, Jatoi A. Does dietary counseling improve quality of life in cancer patients? A systematic review and meta-analysis. J Support Oncol. 2008;6:234\u20137.","journal-title":"J Support Oncol"},{"key":"829_CR30","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1007\/s00520-003-0486-0","volume":"11","author":"N Sarhill","year":"2003","unstructured":"Sarhill N, Mahmoud F, Walsh D, et al. Evaluation of nutritional status in advanced metastatic cancer. Support Care Cancer. 2003;11:652\u20139.","journal-title":"Support Care Cancer"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-021-00829-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11864-021-00829-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-021-00829-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T07:34:14Z","timestamp":1744184054000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11864-021-00829-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,27]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["829"],"URL":"https:\/\/doi.org\/10.1007\/s11864-021-00829-0","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,27]]},"assertion":[{"value":"18 January 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Not applicable. Consent to participate is not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Christopher Ehret declares that he has no conflict of interest. Aminah Jatoi declares that he has no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"31"}}